NEVVI Medicare utilization intelligence
or

← back

Provider profile

CHALLAGUNDLA, SUNEETHA MD

Medical Oncology · NPI 1285836098 · SAN ANTONIO, TX

1
Groups
74
Codes · 2024
48,888
Disclosed services

CHALLAGUNDLA, SUNEETHA is a Medical Oncology in SAN ANTONIO, TX, a member of 1 medical group, who billed 74 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

48,888
disclosed services
74
codes billed to Medicare Part B
Prior year · CY2023 85,778 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1453 Injection, fosaprepitant, 1 mg
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
88185 Flow cytometry technique for dna or cell analysis, each additional marker
36415 Insertion of needle into vein for collection of blood sample
80053 Blood test, comprehensive group of blood chemicals
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J2469 Injection, palonosetron hcl, 25 mcg
J1626 Injection, granisetron hydrochloride, 100 mcg
82784 Gammaglobulin (immune system protein) measurement
83615 Lactate dehydrogenase (enzyme) level
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
83521 Measurement of immunoglobulin light chains
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96413 Administration of chemotherapy into vein, 1 hour or less
96375 Injection of additional new drug or substance into vein
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J2506 Injection, pegfilgrastim, excludes biosimilar, 0.5 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
85055 Reticulated (young) platelet measurement
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
82607 Cyanocobalamin (vitamin b-12) level
82746 Folic acid level, serum
J3489 Injection, zoledronic acid, 1 mg
85379 Coagulation function measurement, d-dimer; quantitative
J9045 Injection, carboplatin, 50 mg
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82232 Beta-2 microglobulin (protein) level
85610 Blood test, clotting time
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
88184 Flow cytometry technique for dna or cell analysis, first marker
J1200 Injection, diphenhydramine hcl, up to 50 mg
84443 Blood test, thyroid stimulating hormone (tsh)
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
85046 Red blood count automated, with additional calculations
96415 Administration of chemotherapy into vein, each additional hour
96417 Administration of additional new drug or substance into vein, 1 hour or less
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
82378 Carcinoembryonic antigen (cea) protein level
85652 Red blood cell sedimentation rate, to detect inflammation, automated
96523 Irrigation of implanted venous access drug delivery device
G6015 Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session
84550 Uric acid level, blood
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
G6013 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
J7030 Infusion, normal saline solution , 1000 cc
82270 Stool analysis for blood to screen for colon tumors
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
J3490 Unclassified drugs
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96411 Administration of additional new drug or substance into vein using push technique
96377 Application of on-body injector for under skin injection
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
99195 Drawing of blood for a medical problem
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
78816 Nuclear medicine study whole body with ct scan
J1720 Injection, hydrocortisone sodium succinate, up to 100 mg
78815 Nuclear medicine study from skull base to mid-thigh with ct scan

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.